Form 483

Legacy Health IRB Form 483, 2014-04-03

FDA issued a Form 483 to Legacy Health IRB on 2014-04-03 with 6 public-safe observations.

483· Form 483 issuedHuman Drugs6 observations

Legacy Health IRB · Portland, United States · Issued April 3, 2014

Overview

  • 6 public-safe observations are available for this inspection.
  • 6 structured CFR citations are represented.
  • 1 investigator is tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

3 Apr 2014
21 CFR 56.107(c)

One scientific and one non-scientific member

Cited by Marijo B Kambere

3 Apr 2014
21 CFR 56.107(e)

Conflict of interest

Cited by Marijo B Kambere

3 Apr 2014
21 CFR 56.108(a)(1)

Initial and continuing reviews

Cited by Marijo B Kambere

3 Apr 2014
21 CFR 56.109(h)

Children as subjects

Cited by Marijo B Kambere

3 Apr 2014
21 CFR 56.115(a)(2)

Minutes of IRB meetings

Cited by Marijo B Kambere

Inspected site

LHLegacy Health IRBPortland, United States

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 56.107(c)Cited across public-safe Form 483 observations1x
21 CFR 56.107(e)Cited across public-safe Form 483 observations1x
21 CFR 56.108(a)(1)Cited across public-safe Form 483 observations1x
21 CFR 56.109(h)Cited across public-safe Form 483 observations1x
21 CFR 56.115(a)(2)Cited across public-safe Form 483 observations1x
21 CFR 56.115(a)(5)Cited across public-safe Form 483 observations1x

Full 483 report

Get the verbatim text of all 6 observations

Every observation in full, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere